TargetKappa-type opioid receptor(Homo sapiens (Human))
University Of Illinois At Chicago
Curated by ChEMBL
University Of Illinois At Chicago
Curated by ChEMBL
Affinity DataKi: 0.0940nMAssay Description:Displacement of [3H]-U69593 from human kappa opioid receptor expressed in U2OS cells by radioligand binding assayMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Homo sapiens (Human))
University Of Illinois At Chicago
Curated by ChEMBL
University Of Illinois At Chicago
Curated by ChEMBL
Affinity DataKi: 0.100nMAssay Description:Displacement of [3H]-U69593 from human kappa opioid receptor expressed in U2OS cells by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.200nMAssay Description:Inhibition of human coagulation factor 11a using p-nitroaniline as substrate assessed as substrate hydrolysis by spectrophotometricallyMore data for this Ligand-Target Pair
Affinity DataKi: 0.300nMAssay Description:Inhibition of human coagulation factor 11a using p-nitroaniline as substrate assessed as substrate hydrolysis by spectrophotometricallyMore data for this Ligand-Target Pair
Affinity DataKi: 0.300nMAssay Description:Inhibition of human coagulation factor 11a using p-nitroaniline as substrate assessed as substrate hydrolysis by spectrophotometricallyMore data for this Ligand-Target Pair
TargetMu-type opioid receptor(Homo sapiens (Human))
University Of Illinois At Chicago
Curated by ChEMBL
University Of Illinois At Chicago
Curated by ChEMBL
Affinity DataKi: 0.350nMAssay Description:Displacement of [3H]-DAMGO from human mu opioid receptor expressed in CHO-K1 cells by radioligand binding assayMore data for this Ligand-Target Pair
TargetMu-type opioid receptor(Homo sapiens (Human))
University Of Illinois At Chicago
Curated by ChEMBL
University Of Illinois At Chicago
Curated by ChEMBL
Affinity DataKi: 0.350nMAssay Description:Displacement of [3H]-DAMGO from human mu opioid receptor expressed in CHO-K1 cells by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 0.800nMAssay Description:Inhibition of human coagulation factor 11a using p-nitroaniline as substrate assessed as substrate hydrolysis at 37 degC by spectrophotometricallyMore data for this Ligand-Target Pair
TargetDelta-type opioid receptor(Homo sapiens (Human))
University Of Illinois At Chicago
Curated by ChEMBL
University Of Illinois At Chicago
Curated by ChEMBL
Affinity DataKi: 1.20nMAssay Description:Displacement of [3H]-DPDPE from human delta opioid receptor expressed in CHO-K1 cells by radioligand binding assayMore data for this Ligand-Target Pair
TargetDelta-type opioid receptor(Homo sapiens (Human))
University Of Illinois At Chicago
Curated by ChEMBL
University Of Illinois At Chicago
Curated by ChEMBL
Affinity DataKi: 1.30nMAssay Description:Displacement of [3H]-DPDPE from human delta opioid receptor expressed in CHO-K1 cells by radioligand binding assayMore data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrateMore data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrateMore data for this Ligand-Target Pair
Affinity DataKi: 3nMAssay Description:Inhibition of human coagulation factor 11a using p-nitroaniline as substrate assessed as substrate hydrolysis by spectrophotometricallyMore data for this Ligand-Target Pair
Affinity DataKi: 3nMAssay Description:Inhibition of human coagulation factor 11a using p-nitroaniline as substrate assessed as substrate hydrolysis by spectrophotometricallyMore data for this Ligand-Target Pair
Affinity DataKi: 3.20nMAssay Description:Inhibition of human coagulation factor 11a after 10 to 120 minsMore data for this Ligand-Target Pair
Affinity DataKi: 3.70nMAssay Description:Inhibition of human coagulation factor 11a after 10 to 120 minsMore data for this Ligand-Target Pair
Affinity DataKi: 4nMAssay Description:Inhibition of human coagulation factor 11a using p-nitroaniline as substrate assessed as substrate hydrolysis by spectrophotometricallyMore data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 4.30nM ΔG°: -47.3kJ/mole EC50: 14nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
Affinity DataKi: 5nMAssay Description:Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrateMore data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 5.10nM ΔG°: -46.9kJ/mole EC50: 8.64nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
Affinity DataKi: 8nMAssay Description:Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrateMore data for this Ligand-Target Pair
Affinity DataKi: 8.40nMAssay Description:Inhibition of human coagulation factor 11a after 10 to 120 minsMore data for this Ligand-Target Pair
Affinity DataKi: 9nMAssay Description:Inhibition of human coagulation factor 11a using p-nitroaniline as substrate assessed as substrate hydrolysis by spectrophotometricallyMore data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 10nM ΔG°: -45.2kJ/mole EC50: 15nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
Affinity DataKi: 12nMAssay Description:Inhibition of human coagulation factor 11a after 10 to 120 minsMore data for this Ligand-Target Pair
Affinity DataKi: 13nMAssay Description:Inhibition of human coagulation factor 11a after 10 to 120 minsMore data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 14nM ΔG°: -44.4kJ/mole EC50: 23nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 15nM ΔG°: -44.2kJ/mole EC50: 19nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
Affinity DataKi: 20nMAssay Description:Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrateMore data for this Ligand-Target Pair
Affinity DataKi: 21nMAssay Description:Inhibition of human coagulation factor 11a after 10 to 120 minsMore data for this Ligand-Target Pair
Affinity DataKi: 23nMAssay Description:Inhibition of human coagulation trypsin using N-benzoyl-Ile-Glu-(OH, OMe)-Gly-Arg-pNA as substrate by spectrophotometric analysisMore data for this Ligand-Target Pair
Affinity DataKi: 24nMAssay Description:Inhibition of human plasma kallikreinMore data for this Ligand-Target Pair
Affinity DataKi: 30nMAssay Description:Inhibition of human coagulation factor 11a using p-nitroaniline as substrate assessed as substrate hydrolysis by spectrophotometricallyMore data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 33nM ΔG°: -42.3kJ/mole EC50: 41nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
Affinity DataKi: 36nMAssay Description:Displacement of [3H]CP-55,940 from human CB2 receptor expressed in CHO cells incubated for 1 hr by liquid scintillation spectrometryMore data for this Ligand-Target Pair
Affinity DataKi: 41nMAssay Description:Displacement of [3H]CP-55,940 from human CB1 receptor expressed in CHO cells incubated for 1 hr by liquid scintillation spectrometryMore data for this Ligand-Target Pair
Affinity DataKi: 42nMAssay Description:Inhibition of human coagulation factor 11a after 10 to 120 minsMore data for this Ligand-Target Pair
Affinity DataKi: 45nMAssay Description:Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrateMore data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 48nM ΔG°: -41.4kJ/mole EC50: 81nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 50nM ΔG°: -41.3kJ/mole EC50: 130nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
Affinity DataKi: 50nMAssay Description:Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrateMore data for this Ligand-Target Pair
Affinity DataKi: 60nMAssay Description:Inhibition of human plasma kallikrein using H-D-Pro-Phe-Arg-pNA as substrateMore data for this Ligand-Target Pair
Affinity DataKi: 64nMAssay Description:Inhibition of human trypsinMore data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 70nM ΔG°: -40.4kJ/mole EC50: 250nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Homo sapiens (Human))
University Of Illinois At Chicago
Curated by ChEMBL
University Of Illinois At Chicago
Curated by ChEMBL
Affinity DataKi: 89nMAssay Description:Displacement of [3H]-U69593 from human kappa opioid receptor expressed in U2OS cells by radioligand binding assayMore data for this Ligand-Target Pair
TargetKappa-type opioid receptor(Homo sapiens (Human))
University Of Illinois At Chicago
Curated by ChEMBL
University Of Illinois At Chicago
Curated by ChEMBL
Affinity DataKi: 89nMAssay Description:Displacement of [3H]-U69593 from human kappa opioid receptor expressed in U2OS cells by radioligand binding assayMore data for this Ligand-Target Pair
TargetGamma-aminobutyric acid (GABA) B receptor 1/type B receptor subunit 2 [41-940](Rattus norvegicus (rat))
Astrazeneca
Astrazeneca
Affinity DataKi: 94nM ΔG°: -39.7kJ/mole EC50: 220nMpH: 7.4 T: 2°CAssay Description:Inhibition of [3H]GABA binding at GABAB receptor sites in rat brain synaptic membranes by test compounds was measured using a filtration binding assa...More data for this Ligand-Target Pair
Affinity DataKi: 113nMAssay Description:Inhibition of human coagulation factor 11a after 10 to 120 minsMore data for this Ligand-Target Pair
Affinity DataKi: 120nMAssay Description:Inhibition of human coagulation factor 11a using p-nitroaniline as substrate assessed as substrate hydrolysis by spectrophotometricallyMore data for this Ligand-Target Pair
Affinity DataKi: 120nMAssay Description:Inhibition of human coagulation factor 11a after 10 to 120 minsMore data for this Ligand-Target Pair